|
WO2021076444A1
|
|
Methods for treating breast cancer
|
|
WO2020257093A1
|
|
Method for treating asthma
|
|
CN111867678A
|
|
Method for treating melanoma
|
|
CN111670032A
|
|
Methods for preventing or treating alzheimer's disease
|
|
EP3664786A1
|
|
Method for treating schnitzler's syndrome
|
|
US2018290971A1
|
|
Deuterated 3-methanesulfonylpropionitrile
|
|
WO2018129231A1
|
|
Method for treating multiple sclerosis
|
|
CN110167538A
|
|
Method for treating cardiovascular disease
|
|
US2016207881A1
|
|
4-methylsulfonyl-2-butenenitrile and its pharmaceutical use
|
|
US2016206589A1
|
|
Pharmaceutical use of 3-benzylsulfonylpropionitrile
|
|
US2016200675A1
|
|
3, 4-bis-benzylsulfonylbutyronitrile and its pharmaceutical use
|
|
US2016158252A1
|
|
Pharmaceutical composition and use of diethyl (2-cyanoethyl)phosphonate
|
|
US9815781B1
|
|
Process for preparing 3-(methylsulfonyl)propionitrile
|
|
EP3110412A1
|
|
4-benzylsulfonyl-2-butenenitrile
|
|
EP3048886A1
|
|
3, 4-bis-benzylsulfonylbutanenitrile and its pharmaceutical use
|
|
CA2921503A1
|
|
Pharmaceutical composition and use of diethyl(2-cyanoethyl)phosphonate for the treatment of inflammation or pain
|
|
EP2861228A1
|
|
Compounds for treating inflammation and pain
|
